What is the recommended dose of propranolol (beta blocker) for migraine prevention?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Propranolol is recommended for migraine prevention at a dose of 80 to 240 mg per day. This dosage is based on the most recent and highest quality study available, which prioritizes the reduction of morbidity, mortality, and improvement of quality of life as outcomes 1. The medication should be initiated at a low dose and gradually increased until the desired outcomes are achieved. It is essential to consider the patient's economic circumstances, personal preferences, and potential adverse effects during the decision-making process.

Key Considerations

  • The dose of propranolol for migraine prevention can be adjusted based on individual patient response and tolerance.
  • Patients should be educated on the potential benefits and harms of propranolol, including side effects such as fatigue, dizziness, and lowered blood pressure.
  • A thorough medical evaluation is necessary before starting propranolol, especially in patients with certain conditions like asthma, severe bradycardia, and heart block.
  • The use of a headache diary may help determine treatment efficacy and identify analgesic overuse.

Clinical Guidelines

  • The American College of Physicians recommends propranolol as a first-line agent for migraine prevention, with a dosage range of 80 to 240 mg per day 1.
  • The guidelines also suggest considering alternative treatments, such as ACE inhibitors, ARBs, or SSRIs, if propranolol is not tolerated or effective.
  • Behavioral interventions, such as cognitive behavioral therapy or relaxation training, may also be beneficial in reducing migraine frequency and improving quality of life.

From the FDA Drug Label

Migraine: The initial oral dose is 80 mg propranolol hydrochloride extended-release capsules once daily. The usual effective dose range is 160 to 240 mg once daily. The recommended dose of propranolol for migraine prevention is:

  • Initial dose: 80 mg once daily
  • Effective dose range: 160 to 240 mg once daily 2

From the Research

Propranolol Dose for Migraine Prevention

The recommended dose of propranolol for migraine prevention varies, but several studies provide guidance on effective dosing:

  • A study from 1989 3 found that low doses of propranolol, close to or up to 1 mg/kg body weight daily, were effective in controlling migraine attacks in many patients.
  • The same study noted that fewer than a third of patients required higher doses to control migraine attacks.
  • Another study from 2009 4 used a dose of 40 mg per day of propranolol, which was shown to be effective in reducing the frequency and intensity of headache attacks.
  • It is generally recommended to start with a low dose and gradually increase as needed and tolerated, as stated in a 2018 review 5.

Factors Influencing Dose

The optimal dose of propranolol for migraine prevention may depend on individual patient factors, such as:

  • The frequency and severity of migraine attacks
  • The presence of comorbid conditions
  • The patient's response to treatment and tolerance of side effects
  • A 2006 review 6 and a 2006 article 7 recommend considering these factors when selecting a preventive therapy for migraine.

Comparison with Other Treatments

Propranolol is one of several medications that have been shown to be effective for migraine prevention, including:

  • Timolol
  • Amitriptyline
  • Divalproex
  • Sodium valproate
  • Topiramate
  • These medications are considered first-line agents for migraine prevention, as stated in a 2006 review 6 and a 2006 article 7.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The dose of propranolol for migraine prophylaxis. Efficacy of low doses.

Cephalalgia : an international journal of headache, 1989

Research

Medications for migraine prophylaxis.

American family physician, 2006

Research

Which therapy for which patient?

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.